Clinical Trials Sponsored by Walid HABRE

Total 236 results

Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments

Xerosis

France
Pierre Fabre Dermo Cosmetique

Completed

IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Cream)

Hypersensitive | Reactive and Intolerant Skin | Redness-prone Skin | Stinger Subjects

China
Pierre Fabre Medicament
Biotrial

Active, not recruiting

Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Groupe Hospitalier du Havre

Completed

Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection (TELECOVID)

Covid19

France
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

Acne

France
Pierre Fabre Dermo Cosmetique

Completed

An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy (PAP)

Chronic Pruritus Due to Plaque Psoriasis

Spain, France
Pierre Fabre Dermo Cosmetique

Completed

Demonstration of Carbonyl Stress on Hair Follicles

Effluvium; Telogen

France
Groupe Hospitalier du Havre

Completed

Effect of High Flow Nasal During Exercise in COPD Patients (AiRehab)

COPD Exacerbation

France
Groupe Hospitalier du Havre

Completed

Backpack Carrying in Children With Cystic Fibrosis

Cystic Fibrosis

France
Pierre Fabre Dermo Cosmetique

Completed

Avene Compact Honey for Prevention of Pigmentation From Visible Light

Healthy

Canada
Pierre Fabre Dermo Cosmetique

Not yet recruiting

Evaluation of the Tolerance of the Medical Device RL3010A - DP0378 in Children and Adults Presenting a Superficial Wound After a Dermatological Procedure

Skin Abrasion | Superficial Wound
Pierre Fabre Dermo Cosmetique

Not yet recruiting

Evaluate the Efficacy and the Tolerance of the Medical Device V063B-DP3003 on Dentin Hypersensitivity During Teeth Whitening

Tooth Whitening
Groupe Hospitalier du Havre

Recruiting

French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

Lung Diseases | Lung Diseases, Obstructive | Obstructive Pulmonary Disease

France
Pierre Fabre Dermo Cosmetique

Completed

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

Healthy | Rosacea | Seborrheic Dermatitis | Atopic Dermatitis | Psoriasis Vulgaris | Acne

France
Pierre Fabre Dermo Cosmetique

Completed

Re-epithelialization Efficacy Evaluation of Cosmetic Product RV1551P vs Non-treated Forearm of Healthy Adult Women

Healthy

France
Pierre Fabre Dermo Cosmetique

Completed

Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure

Sun Damaged Skin

France
Pierre Fabre Dermo Cosmetique

Completed

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

Sunscreen

France
Pierre Fabre Medicament
Biotrial

Completed

Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Pfizer
Pierre Fabre Laboratories

Terminated

Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma

Melanoma

Italy
Pierre Fabre Medicament
Clinact

Completed

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

Actinic Keratoses

France, Germany, Italy, Spain
Pierre Fabre Dermo Cosmetique

Completed

IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Balm)

Hypersensitive | Reactive and Intolerant Skin | Redness-prone Skin | Stinger Subjects

China
Pierre Fabre Dermo Cosmetique

Completed

Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

Acne

Portugal
Pierre Fabre Dermo Cosmetique

Completed

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

Atopic Dermatitis

France
Groupe Hospitalier du Havre

Completed

Sit-to-stand Test in Cystic Fibrosis Children and Adolescents

Cystic Fibrosis

France
Pierre Fabre Dermo Cosmetique

Completed

Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy

Hyperpigmentation | Lentigo
Pierre Fabre Dermo Cosmetique

Unknown

Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults

Dentinal Hypersensitivity

United Kingdom
Pierre Fabre Dermo Cosmetique

Unknown

Efficacy and Safety of RV4104A Ointment in Onychomycosis

Onychomycosis

France
University of Zurich
Waid City Hospital, Zurich

Completed

Dignity Therapy for Patients With Early Dementia and Their Family (DTD)

Depressive Disorder | Dementia, Mild

Switzerland
Pierre Fabre Dermo Cosmetique
SpinControl

Not yet recruiting

Biological Anti-aging Efficacy of a Cosmetic Night Cream

Healthy
University Hospital, Brest
Fabre Clinic

Completed

Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC. (VINCR)

Lung Neoplasm

France
ARCAGY/ GINECO GROUP
Pierre Fabre Laboratories

Terminated

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer. (CHEOPS)

Breast Cancer

France
University of Aarhus
Pierre Fabre Laboratories

Completed

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer (XeNa)

Breast Cancer

Denmark
University of Lausanne
Pierre Fabre Laboratories

Completed

Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors (ferdon)

Fatigue | Iron Deficiency

Switzerland
Pierre Fabre Pharma GmbH
iOMEDICO AG

Completed

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer | Non Small Cell Lung Carcinoma

Germany
Pierre Fabre Medicament
Bristol-Myers Squibb

Completed

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Bladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial Tract

Canada
Pierre Fabre Dermo Cosmetique
Quanta Medical

Unknown

Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis (ONICO)

Onychomycosis

France
Pierre Fabre Medicament
Iqvia Pty Ltd

Recruiting

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib (NEAR)

Breast Cancer | HER2-positive Breast Cancer | Adjuvant Therapy

Belgium
University Hospital, Limoges
Pierre Fabre Laboratories

Completed

Concomitant Radio-chemotherapy in the Elderly (RACCOSA)

Non Small Cell Lung Cancer

France
Bristol-Myers Squibb
Pierre Fabre Medicament

Completed

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Kidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, Bladder

United States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
Cairo University
Samuel Bekhet Moawad; Ahmed Shaker Ragab; Michael Wahib Wadid

Completed

U/S Guided SAB VS U/S Guided SAB With Modified Pectoral Nerve Block in Modified Radical Mastectomy

U/S Guided SAB VS U/S Guided SAB Combined With Modified Pectoral Nerve Block

Egypt
Pierre Fabre Medicament
Iqvia Pty Ltd

Recruiting

A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

BRAF V600 Mutation | Metastatic Non-small Cell Lung Cancer

France
Pierre Fabre Pharma GmbH
Winicker Norimed GmbH

Completed

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria (StepUp)

Breast Cancer | Non-Small-Cell Lung Cancer

Germany, Austria
Joshua M Hare

Withdrawn

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 (COVID-19)

COVID-19 | Acute Respiratory Distress Syndrome | Corona Virus Infection
Leiden University Medical Center
Pierre Fabre Laboratories

Recruiting

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Melanoma Stage III | In-Transit Metastasis of Cutaneous Melanoma

Netherlands
Joshua M Hare

Withdrawn

Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis (HAPI)

Cystic Fibrosis
Joshua M Hare

Withdrawn

AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) (GALENE)

Crohn's Disease | Stem Cells | Fistulizing Crohn's Disease

United States
Joshua M Hare

Terminated

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression (ANU)

Treatment Resistant Depression

United States
University Hospital, Rouen
Groupe Hospitalier du Havre

Not yet recruiting

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach (ANOTES)

Hysterotomy; Affecting Fetus
Pierre Fabre Medicament
Merck KGaA, Darmstadt, Germany

Active, not recruiting

A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer. (NAUTICALCRC)

Metastatic Colorectal Cancer | BRAF V600E

China
Wales Cancer Trials Unit
Pierre Fabre Laboratories

Completed

Vinorelbine in Mesothelioma (VIM)

Mesothelioma

United Kingdom

3

Subscribe